Select Medical Holdings Completes Senior Notes Offering
Select Medical Holdings Corporation (NYSE: SEM) has successfully completed a private offering of $550.0 million in aggregate principal amount of 6.250% senior notes due 2032. This significant achievement reflects the company's strategic financial planning aimed at bolstering its capabilities and ensuring its long-term stability.
Utilization of Proceeds from the Offering
The proceeds from this offering are primarily allocated to important financial adjustments. Select Medical intends to use the net proceeds, along with funds from a new incremental term loan and existing cash, to fully repay its outstanding term loans under its current senior secured credit agreement. Additionally, the company plans to redeem all of its outstanding 6.250% senior notes due 2026, thereby optimizing its financial structure.
Understanding the Nature of the Senior Notes
The senior notes issued by Select Medical are classified as senior unsecured obligations, which means they hold a significant position in the capital structure of the company. Furthermore, these notes are guaranteed by several domestic subsidiaries of Select Medical. Investors who purchased these notes are assured of their considerations being prioritized in terms of repayment.
Compliance and Regulatory Aspects
It is important to note that these notes and associated guarantees were not registered under the Securities Act of 1933 or any other securities laws, meaning they cannot be offered or sold in regions requiring such registrations unless an exemption applies. The offering was exclusive to qualified institutional buyers in accordance with Rule 144A of the Securities Act, promoting a structured and compliant investment environment.
Implications for Future Financial Strategies
The completion of this offering positions Select Medical favorably as it enhances its financial footing in a challenging economic landscape. By redeeming older notes and repaying existing loans, the company not only mitigates financial risks but might also lower its interest expenses, thereby fostering a more sustainable operation.
Investor Communication and Contact
The management team at Select Medical is committed to maintaining transparency and active communication with its investors. Anyone seeking further information or who has inquiries regarding this development may contact Joel T. Veit, Senior Vice President and Treasurer at Select Medical Holdings. His direct line is 717-972-1100 for any investor-related questions.
Frequently Asked Questions
What prompted Select Medical to issue the senior notes?
Select Medical initiated the offering to repay existing debt and improve its financial positioning.
How will the proceeds from the notes be used?
The net proceeds will be used to pay off term loans and redeem older senior notes.
Are the senior notes transferable?
Yes, but they are subject to restrictions due to their unregistered status under the Securities Act.
Who can buy these senior notes?
The offering was made exclusively to qualified institutional buyers.
Where can I get more information about Select Medical's financial status?
For more information, investors can contact the company's Senior Vice President and Treasurer or check their regular SEC filings.
